IFI35


Description

The IFI35 (interferon induced protein 35) is a protein-coding gene located on chromosome 17.

IFI35, also known as interferon-induced 35 kDa protein, is a protein encoded by the IFI35 gene in humans.

IFI35 acts as a signaling pathway regulator in the innate immune system. It interacts with NMI to regulate immune responses, preventing proteasome-mediated degradation and dephosphorylation of IFI35. The complex inhibits virus-triggered type I interferon production and negatively regulates NF-kappa-B signaling by inhibiting nuclear translocation and activation of the NF-kappa-B subunit p65/RELA. This inhibition leads to the suppression of endothelial cell proliferation, migration, and re-endothelialization of injured arteries. IFI35 also functions extracellularly as a damage-associated molecular pattern (DAMP) to promote inflammation. Released by macrophages during cell injury and pathogen invasion, it activates NF-kappa-B signaling in adjacent macrophages via Toll-like receptor 4 (TLR4), promoting the release of pro-inflammatory cytokines.

IFI35 is also known as IFP35.

Associated Diseases



Disclaimer

The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.